Annual EBIT
-$4.70 M
-$131.00 K-2.87%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual earnings before interest & taxes is -$4.70 million, with the most recent change of -$131.00 thousand (-2.87%) on March 31, 2024.
- During the last 3 years, SNOA annual EBIT has fallen by -$1.25 million (-36.30%).
- SNOA annual EBIT is now -198.08% below its all-time high of $4.79 million, reached on March 31, 2014.
Performance
SNOA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.03 M
-$181.00 K-21.29%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly earnings before interest & taxes is -$1.03 million, with the most recent change of -$181.00 thousand (-21.29%) on December 31, 2024.
- Over the past year, SNOA quarterly EBIT has dropped by -$187.00 thousand (-22.16%).
- SNOA quarterly EBIT is now -113.82% below its all-time high of $7.46 million, reached on March 31, 2014.
Performance
SNOA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$4.46 M
-$187.00 K-4.37%
December 31, 2024
Summary
- As of February 7, 2025, SNOA TTM earnings before interest & taxes is -$4.46 million, with the most recent change of -$187.00 thousand (-4.37%) on December 31, 2024.
- Over the past year, SNOA TTM EBIT has dropped by -$24.00 thousand (-0.54%).
- SNOA TTM EBIT is now -166.79% below its all-time high of $6.68 million, reached on September 30, 2014.
Performance
SNOA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SNOA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.9% | -22.2% | -0.5% |
| 3 y3 years | -36.3% | +10.1% | +2.3% |
| 5 y5 years | +58.4% | +10.1% | +2.3% |
SNOA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.3% | +20.1% | -41.0% | +66.3% | -4.4% | +31.1% |
| 5 y | 5-year | -36.3% | +58.4% | -710.1% | +66.3% | -89.8% | +31.1% |
| alltime | all time | -198.1% | +79.0% | -113.8% | +95.5% | -166.8% | +80.6% |
Sonoma Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$1.03 M(+21.3%) | -$4.46 M(+4.4%) |
| Sep 2024 | - | -$850.00 K(-27.5%) | -$4.28 M(-7.7%) |
| Jun 2024 | - | -$1.17 M(-16.7%) | -$4.63 M(-1.4%) |
| Mar 2024 | -$4.70 M(+2.9%) | -$1.41 M(+66.9%) | -$4.70 M(+5.9%) |
| Dec 2023 | - | -$844.00 K(-30.1%) | -$4.44 M(-18.2%) |
| Sep 2023 | - | -$1.21 M(-2.6%) | -$5.43 M(+9.6%) |
| Jun 2023 | - | -$1.24 M(+8.1%) | -$4.95 M(+8.4%) |
| Mar 2023 | -$4.57 M(-22.4%) | -$1.15 M(-37.5%) | -$4.57 M(-29.5%) |
| Dec 2022 | - | -$1.83 M(+150.9%) | -$6.48 M(+15.6%) |
| Sep 2022 | - | -$731.00 K(-14.5%) | -$5.60 M(-4.0%) |
| Jun 2022 | - | -$855.00 K(-72.1%) | -$5.84 M(-0.8%) |
| Mar 2022 | -$5.89 M(+70.7%) | -$3.06 M(+219.4%) | -$5.89 M(+4.4%) |
| Dec 2021 | - | -$958.00 K(-0.6%) | -$5.64 M(+17.0%) |
| Sep 2021 | - | -$964.00 K(+6.6%) | -$4.82 M(+30.7%) |
| Jun 2021 | - | -$904.00 K(-67.9%) | -$3.69 M(+6.9%) |
| Mar 2021 | -$3.45 M(-2.2%) | -$2.81 M(+1939.1%) | -$3.45 M(+46.7%) |
| Dec 2020 | - | -$138.00 K(-181.7%) | -$2.35 M(-31.3%) |
| Sep 2020 | - | $169.00 K(-125.4%) | -$3.42 M(-29.8%) |
| Jun 2020 | - | -$665.00 K(-61.3%) | -$4.88 M(+38.2%) |
| Mar 2020 | -$3.53 M(-68.8%) | -$1.72 M(+42.0%) | -$3.53 M(-22.8%) |
| Dec 2019 | - | -$1.21 M(-6.0%) | -$4.57 M(-19.2%) |
| Sep 2019 | - | -$1.29 M(-288.0%) | -$5.65 M(-21.3%) |
| Jun 2019 | - | $684.00 K(-124.8%) | -$7.18 M(-36.5%) |
| Mar 2019 | -$11.31 M(-20.6%) | -$2.76 M(+20.3%) | -$11.31 M(-14.7%) |
| Dec 2018 | - | -$2.29 M(-18.6%) | -$13.25 M(-6.3%) |
| Sep 2018 | - | -$2.81 M(-18.4%) | -$14.14 M(-0.3%) |
| Jun 2018 | - | -$3.45 M(-26.7%) | -$14.19 M(-0.4%) |
| Mar 2018 | -$14.24 M(+10.1%) | -$4.70 M(+48.1%) | -$14.24 M(+12.2%) |
| Dec 2017 | - | -$3.18 M(+11.0%) | -$12.69 M(-3.0%) |
| Sep 2017 | - | -$2.86 M(-18.2%) | -$13.08 M(-1.0%) |
| Jun 2017 | - | -$3.50 M(+10.8%) | -$13.21 M(-0.1%) |
| Mar 2017 | -$12.93 M(-12.1%) | -$3.16 M(-11.5%) | -$13.22 M(-3.7%) |
| Dec 2016 | - | -$3.56 M(+19.1%) | -$13.73 M(-4.5%) |
| Sep 2016 | - | -$2.99 M(-14.6%) | -$14.38 M(+9.4%) |
| Jun 2016 | - | -$3.50 M(-4.3%) | -$13.14 M(+9.7%) |
| Mar 2016 | -$14.72 M(+79.5%) | -$3.66 M(-13.1%) | -$11.98 M(+22.0%) |
| Dec 2015 | - | -$4.21 M(+139.2%) | -$9.82 M(+30.0%) |
| Sep 2015 | - | -$1.76 M(-24.7%) | -$7.55 M(+16.1%) |
| Jun 2015 | - | -$2.34 M(+55.8%) | -$6.51 M(+53.7%) |
| Mar 2015 | -$8.20 M(-271.1%) | -$1.50 M(-22.9%) | -$4.24 M(-189.6%) |
| Dec 2014 | - | -$1.95 M(+171.8%) | $4.73 M(-29.3%) |
| Sep 2014 | - | -$717.00 K(+970.1%) | $6.68 M(+8.0%) |
| Jun 2014 | - | -$67.00 K(-100.9%) | $6.19 M(+29.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | $4.79 M(-210.8%) | $7.46 M(>+9900.0%) | $4.79 M(-198.9%) |
| Dec 2013 | - | $7000.00(-100.6%) | -$4.85 M(-25.3%) |
| Sep 2013 | - | -$1.21 M(-17.2%) | -$6.49 M(+6.5%) |
| Jun 2013 | - | -$1.46 M(-33.0%) | -$6.10 M(+56.3%) |
| Mar 2013 | -$4.32 M(-32.4%) | -$2.18 M(+33.2%) | -$3.90 M(+21.6%) |
| Dec 2012 | - | -$1.64 M(+100.4%) | -$3.21 M(-16.8%) |
| Sep 2012 | - | -$817.00 K(-211.5%) | -$3.86 M(+5.1%) |
| Jun 2012 | - | $733.00 K(-149.2%) | -$3.67 M(-42.8%) |
| Mar 2012 | -$6.40 M(-14.8%) | -$1.49 M(-34.9%) | -$6.42 M(+1.6%) |
| Dec 2011 | - | -$2.29 M(+263.0%) | -$6.32 M(+3.4%) |
| Sep 2011 | - | -$630.00 K(-68.8%) | -$6.11 M(-14.2%) |
| Jun 2011 | - | -$2.02 M(+45.6%) | -$7.13 M(-5.0%) |
| Mar 2011 | -$7.50 M(-6.4%) | -$1.39 M(-33.3%) | -$7.50 M(-0.9%) |
| Dec 2010 | - | -$2.08 M(+26.3%) | -$7.57 M(+1.0%) |
| Sep 2010 | - | -$1.65 M(-31.3%) | -$7.50 M(-7.5%) |
| Jun 2010 | - | -$2.40 M(+64.7%) | -$8.11 M(+1.2%) |
| Mar 2010 | -$8.02 M(-53.7%) | -$1.46 M(-27.4%) | -$8.02 M(-9.0%) |
| Dec 2009 | - | -$2.00 M(-11.1%) | -$8.81 M(-11.4%) |
| Sep 2009 | - | -$2.25 M(-2.0%) | -$9.94 M(-30.5%) |
| Jun 2009 | - | -$2.30 M(+2.4%) | -$14.32 M(-16.2%) |
| Mar 2009 | -$17.31 M(-22.8%) | -$2.25 M(-28.4%) | -$17.09 M(-17.1%) |
| Dec 2008 | - | -$3.14 M(-52.6%) | -$20.62 M(-10.5%) |
| Sep 2008 | - | -$6.63 M(+30.6%) | -$23.03 M(+4.3%) |
| Jun 2008 | - | -$5.07 M(-12.2%) | -$22.08 M(-1.5%) |
| Mar 2008 | -$22.43 M(+15.1%) | -$5.78 M(+4.0%) | -$22.43 M(+0.0%) |
| Dec 2007 | - | -$5.55 M(-2.2%) | -$22.42 M(+2.0%) |
| Sep 2007 | - | -$5.68 M(+4.9%) | -$21.98 M(+95.3%) |
| Jun 2007 | - | -$5.42 M(-6.1%) | -$11.25 M(+140.8%) |
| Mar 2007 | -$19.48 M(-6.6%) | -$5.77 M(+12.8%) | -$4.67 M(-78.4%) |
| Dec 2006 | - | -$5.12 M(-201.3%) | -$21.59 M(+37.3%) |
| Sep 2006 | - | $5.05 M(+333.4%) | -$15.72 M(-22.3%) |
| Jun 2006 | - | $1.17 M(-105.1%) | -$20.23 M(-3.0%) |
| Mar 2006 | -$20.85 M(+27.8%) | -$22.68 M(-3120.5%) | -$20.85 M(+34.6%) |
| Dec 2005 | - | $751.00 K(+38.8%) | -$15.50 M(-2.6%) |
| Sep 2005 | - | $541.00 K(0.0%) | -$15.91 M(-1.3%) |
| Jun 2005 | - | $541.00 K(-103.1%) | -$16.11 M(-1.2%) |
| Mar 2005 | -$16.31 M(-1908.4%) | -$17.33 M(-5211.8%) | -$16.31 M(-1703.9%) |
| Dec 2004 | - | $339.00 K(0.0%) | $1.02 M(+50.0%) |
| Sep 2004 | - | $339.00 K(0.0%) | $678.00 K(+100.0%) |
| Jun 2004 | - | $339.00 K | $339.00 K |
| Mar 2004 | $902.00 K(-161.4%) | - | - |
| Mar 2003 | -$1.47 M(+898.6%) | - | - |
| Mar 2002 | -$147.00 K | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual EBIT year-on-year change?
- What is Sonoma Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly EBIT year-on-year change?
- What is Sonoma Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM EBIT year-on-year change?
What is Sonoma Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SNOA is -$4.70 M
What is the all time high annual EBIT for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual earnings before interest & taxes is $4.79 M
What is Sonoma Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SNOA annual earnings before interest & taxes has changed by -$131.00 K (-2.87%)
What is Sonoma Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SNOA is -$1.03 M
What is the all time high quarterly EBIT for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly earnings before interest & taxes is $7.46 M
What is Sonoma Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SNOA quarterly earnings before interest & taxes has changed by -$187.00 K (-22.16%)
What is Sonoma Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SNOA is -$4.46 M
What is the all time high TTM EBIT for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM earnings before interest & taxes is $6.68 M
What is Sonoma Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SNOA TTM earnings before interest & taxes has changed by -$24.00 K (-0.54%)